Skip to content
HowShorted

How shorted is Cue Biopharma, Inc.? CUE

#1,823most shorted US stockof 3,805 ranked stocks, more shorted than 52%

4.57%
of shares outstanding reported short ยท settlement date 15 Sep 2026
vs previous report
+0.19
5 reports (~10 weeks)
+4.10
days to cover
2.44
Aggregate net short position time series for Cue Biopharma, Inc.

Markers along the chart's base: โ–ฒ results announced (an 8-K reporting results was filed) โ–ฒ quarterly or annual report filed. Dates are SEC filing dates; hover a point to see events since the previous settlement.

Days to cover

FINRA's own figure: reported shares short divided by the stock's average daily trading volume, published alongside each settlement. It expresses the short position in days of typical trading rather than as a percentage of the company; the two can move differently.

Aggregate net short position time series for Cue Biopharma, Inc. days to cover

Short interest around results

For each results announcement (an 8-K reporting results, by its SEC filing date), the FINRA settlement before it and the first one after. Settlements fall twice a month, so the two figures can sit up to a month apart and much else changes in between: this shows what was reported, not why.

Reported short interest before and after each results announcement
Results filedSettlement beforeSettlement afterChange
16 Mar 20262.33% 13 Mar 20262.73% 31 Mar 2026+0.40
12 Nov 20250.48% 31 Oct 20250.65% 14 Nov 2025+0.17
12 Aug 20251.40% 31 Jul 20251.25% 15 Aug 2025โˆ’0.15
12 May 20251.40% 30 Apr 20251.44% 15 May 2025+0.04
15 Apr 20251.38% 31 Mar 20251.40% 30 Apr 2025+0.02
31 Mar 20251.36% 14 Mar 20251.43% 15 Apr 2025+0.07
14 Nov 20243.66% 31 Oct 20241.69% 15 Nov 2024โˆ’1.97
9 May 202410.19% 30 Apr 20249.44% 15 May 2024โˆ’0.75

Fails to deliver

The SEC's fails-to-deliver figure for CUE: the aggregate net balance of shares that failed to be delivered at each settlement date, published by the SEC twice a month and shown here verbatim for the trailing window. A balance is not a daily flow, and a fail has many ordinary causes; the SEC says it cannot guarantee the accuracy of the data. See what fails to deliver are and the largest balances today.

Last balance on file
180
11 Sep 2026
Highest in window
1,503,120
8 Apr 2026
Days with a balance
72
Window
16 Sep 2025 to 14 Sep 2026
Aggregate net short position time series for Cue Biopharma, Inc. fails to deliver

Source: U.S. Securities and Exchange Commission, fails-to-deliver data (public domain). Only settlement days with a positive balance appear; the largest balance in the window was 1.5M shares.

Embed this chart

Paste this snippet to embed the interactive chart. It updates with each FINRA report and keeps the source attribution. Preview

Download chart cardShare on XRedditLinkedIn
Cite this page
Plain
Wikipedia
BibTeX

Sector: Healthcare

History

Full reported short interest history
Settlement dateShort %Change
15 Sep 20264.57%+0.19
31 Aug 20264.38%โˆ’0.13
14 Aug 20264.51%+1.78
31 Mar 20262.73%+0.40
13 Mar 20262.33%+1.86
15 Dec 20250.47%โˆ’0.09
28 Nov 20250.56%โˆ’0.09
14 Nov 20250.65%+0.17
31 Oct 20250.48%+0.03
15 Oct 20250.45%โˆ’0.36
30 Sep 20250.81%โˆ’0.06
15 Sep 20250.87%โˆ’0.30
29 Aug 20251.17%โˆ’0.08
15 Aug 20251.25%โˆ’0.15
31 Jul 20251.40%โˆ’0.40
15 Jul 20251.80%โˆ’0.08
30 Jun 20251.88%+0.53
13 Jun 20251.35%+0.10
30 May 20251.25%โˆ’0.19
15 May 20251.44%+0.04
30 Apr 20251.40%โˆ’0.03
15 Apr 20251.43%+0.05
31 Mar 20251.38%+0.02
14 Mar 20251.36%โˆ’0.15
28 Feb 20251.51%โˆ’0.10
14 Feb 20251.61%โˆ’0.12
31 Jan 20251.73%+0.02
15 Jan 20251.71%โˆ’0.35
31 Dec 20242.06%+0.36
13 Dec 20241.70%+0.11
29 Nov 20241.59%โˆ’0.10
15 Nov 20241.69%โˆ’1.97
31 Oct 20243.66%โˆ’0.34
15 Oct 20244.00%โˆ’3.81
30 Sep 20247.81%+0.50
13 Sep 20247.31%+0.26
30 Aug 20247.05%โˆ’0.47
15 Aug 20247.52%โˆ’0.77
31 Jul 20248.29%+0.64
15 Jul 20247.65%โˆ’2.10
28 Jun 20249.75%+0.51
14 Jun 20249.24%+0.30
31 May 20248.94%โˆ’0.50
15 May 20249.44%โˆ’0.75
30 Apr 202410.19%+0.37
15 Apr 20249.82%+1.18
28 Mar 20248.64%โˆ’0.49
15 Mar 20249.13%+0.33
29 Feb 20248.80%+0.36
15 Feb 20248.44%+0.45
31 Jan 20247.99%โˆ’0.11
12 Jan 20248.10%+0.52
29 Dec 20237.58%+0.37
15 Dec 20237.21%+0.55
30 Nov 20236.66%โˆ’0.05
15 Nov 20236.71%โˆ’0.21
31 Oct 20236.92%+1.13
13 Oct 20235.79%+0.14
29 Sep 20235.65%+0.15
15 Sep 20235.50%+0.07
31 Aug 20235.43%โˆ’1.38
15 Aug 20236.81%โˆ’0.73
31 Jul 20237.54%+1.76
14 Jul 20235.78%+1.27
30 Jun 20234.51%+2.64
15 Jun 20231.87%+0.18
31 May 20231.69%+0.45
15 May 20231.24%+0.01
28 Apr 20231.23%โˆ’0.34
14 Apr 20231.57%โˆ’0.19
31 Mar 20231.76%+0.46
15 Mar 20231.30%0.00
28 Feb 20231.30%+0.06
15 Feb 20231.24%โˆ’0.18
31 Jan 20231.42%โˆ’0.40
13 Jan 20231.82%+0.15
30 Dec 20221.67%โˆ’0.36
15 Dec 20222.03%โˆ’0.12
30 Nov 20222.15%โˆ’0.31
15 Nov 20222.46%โˆ’1.04
31 Oct 20223.50%โˆ’0.42
14 Oct 20223.92%โˆ’0.26
30 Sep 20224.18%โˆ’0.59
15 Sep 20224.77%โˆ’0.72
31 Aug 20225.49%+0.02
15 Aug 20225.47%โˆ’1.14
29 Jul 20226.61%โˆ’0.01
15 Jul 20226.62%โˆ’0.25
30 Jun 20226.87%โˆ’3.99
15 Jun 202210.86%โˆ’1.02
31 May 202211.88%โˆ’0.56
13 May 202212.44%0.00
29 Apr 202212.44%+1.62
14 Apr 202210.82%+0.68
31 Mar 202210.14%โˆ’1.43
15 Mar 202211.57%+0.49
28 Feb 202211.08%+0.17
15 Feb 202210.91%+2.44
31 Jan 20228.47%+1.30
14 Jan 20227.17%+0.76
31 Dec 20216.41%+0.63
15 Dec 20215.78%+0.54
30 Nov 20215.24%โˆ’0.49
15 Nov 20215.73%โˆ’0.69
29 Oct 20216.42%+0.20
15 Oct 20216.22%โˆ’0.17
30 Sep 20216.39%โˆ’1.16
15 Sep 20217.55%โˆ’0.37
31 Aug 20217.92%โˆ’0.19
13 Aug 20218.11%โˆ’0.56
30 Jul 20218.67%โˆ’0.20
15 Jul 20218.87%โˆ’0.04
30 Jun 20218.91%+0.13
15 Jun 20218.78%โˆ’0.58
28 May 20219.36%โˆ’0.52
14 May 20219.88%+1.39
30 Apr 20218.49%โˆ’1.00
15 Apr 20219.49%โˆ’0.81
31 Mar 202110.30%+0.99
15 Mar 20219.31%+0.13
26 Feb 20219.18%+0.06
12 Feb 20219.12%โˆ’0.57
29 Jan 20219.69%+0.15
15 Jan 20219.54%+0.42
31 Dec 20209.12%+0.31
15 Dec 20208.81%โˆ’0.63
30 Nov 20209.44%โˆ’0.07
13 Nov 20209.51%+0.27
30 Oct 20209.24%+0.90
15 Oct 20208.34%โˆ’0.51
30 Sep 20208.85%+0.98
15 Sep 20207.87%+0.55
31 Aug 20207.32%โˆ’0.09
14 Aug 20207.41%โˆ’0.70
31 Jul 20208.11%+0.14
15 Jul 20207.97%+1.43
30 Jun 20206.54%+3.91
15 Jun 20202.63%+0.29
29 May 20202.34%โˆ’1.37
15 May 20203.71%+0.40
30 Apr 20203.31%โˆ’0.62
15 Apr 20203.93%โˆ’1.82
31 Mar 20205.75%+1.30
13 Mar 20204.45%โˆ’0.32
28 Feb 20204.77%+0.21
14 Feb 20204.56%โˆ’0.11
31 Jan 20204.67%+0.42
15 Jan 20204.25%+0.12
31 Dec 20194.13%+0.15
13 Dec 20193.98%โˆ’0.12
29 Nov 20194.10%โˆ’0.12
15 Nov 20194.22%โˆ’0.41
31 Oct 20194.63%โˆ’0.15
15 Oct 20194.78%โ€“

Newest first. Scroll inside the table for earlier dates, back to 15 Oct 2019.

Frequently asked questions

How shorted is Cue Biopharma, Inc. right now?
4.57% of Cue Biopharma, Inc.'s (CUE) shares outstanding were reported short for settlement date 15 Sep 2026, per FINRA's consolidated short interest report. That makes it the 1,823rd most shorted US stock, out of 3,805 we rank.
What does this number include?
FINRA member firms must report their short positions in all US equities twice a month; FINRA consolidates them per security. We divide that official share count by the company's shares outstanding from its SEC filings. This is the regulatory figure, not a daily estimate.
Why does it only update twice a month?
US short interest is reported for settlement on the 15th and the last business day of each month, and FINRA publishes the consolidated figures about nine business days later. That cadence is set by regulation; no daily official figure exists.
Is this CUE's short float?
No. This is short interest as a percentage of shares outstanding, the count in the company's SEC filings. "Short float" divides the same FINRA short count by the public float, which excludes closely held shares, so it comes out higher for the same company. We publish no float estimates: the float is not a regulatory figure.
What is CUE's days to cover?
2.44 days for settlement date 15 Sep 2026: FINRA's own short interest ratio, the reported shares short divided by average daily trading volume. It is published in the same FINRA file and shown verbatim; we hold no volume data ourselves.
Which funds are short?
US public short interest is aggregate-only: individual short sellers are not named. Only some EU markets publish named positions.